A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis

scientific article published on 01 May 2006

A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1032386471
P356DOI10.1007/S10620-005-9071-3
P698PubMed publication ID16773434

P2093author name stringCharles J Lightdale
Clara Hwang
Bernard Hamelin
Colleen Schmitt
P2860cites workEndoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationQ24670182
Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux diseaseQ31404948
Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitisQ31811132
Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazoleQ34320782
Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitisQ34409644
Epidemiology and natural history of gastro-oesophageal reflux diseaseQ35378865
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study GroupQ39442247
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysisQ39455544
Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.Q39469901
Critical issues in the management of gastroesophageal reflux disease.Q39474663
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter studyQ39504404
The pathogenesis of gastroesophageal reflux disease: the relationship between epithelial defense, dysmotility, and acid exposureQ41451958
The endoscopic assessment of esophagitis: a progress report on observer agreement.Q52888202
An evidence-based appraisal of reflux disease management--the Genval Workshop ReportQ61537811
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialQ61826600
Appropriate acid suppression for the management of gastro-oesophageal reflux diseaseQ67555208
The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new conceptsQ77929702
P433issue5
P921main subjectesophagitisQ298230
omeprazoleQ422210
esomeprazoleQ553223
multicenter clinical trialQ6934595
P304page(s)852-857
P577publication date2006-05-01
P1433published inDigestive Diseases and SciencesQ15716711
P1476titleA multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis
P478volume51

Reverse relations

cites work (P2860)
Q42283418Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis
Q40316973Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.
Q35987201Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
Q37032564Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults
Q48458474Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: con.
Q33446555GORD in adults
Q24289016Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
Q37260543Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole
Q43854731Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials

Search more.